Scott Canna - Concepedia

Author

Scott Canna

Children's Hospital of Philadelphia ORCID

Also Known As

B Cameron, B. Cameron, D. Bullock, Emily Landy, Fleisher, Thomas A, Hermine Brunner, Lauren Henderson, M. Buckley, Penzak, Scott R., Portia A. Kreiger

194

Publications

10K

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Philadelphia Children's Hospital of Pittsburgh University of Pittsburgh University of Pennsylvania Cincinnati Children's Hospital Medical Center

About

Scott Canna is an author at Children's Hospital of Philadelphia specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.7K
2	Immunology	10	10	1.6K
3	Cell Biology	4	4	1.2K
4	Allergy	1	1	21
5	Clinical Immunology	1	1	31

Scott Canna

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition Raphaela Goldbach‐Mansky, Natalie Dailey Garnes, Scott Canna, New England Journal of Medicine	2006	888
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome Scott Canna, Adriana A. de Jesus, Sushanth Gouni, Nature Genetics InflammationImmune Cell DevelopmentMedicineImmunologyChronic Inflammation	2014	725
On the Alert for Cytokine Storm: Immunopathology in <scp>COVID</scp>‐19 Lauren A. Henderson, Scott Canna, Grant S. Schulert, Arthritis & Rheumatology	2020	640
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 Lauren A. Henderson, Scott Canna, Kevin G. Friedman, Arthritis & Rheumatology	2020	529
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 Lauren A. Henderson, Scott Canna, Kevin G. Friedman, Arthritis & Rheumatology	2020	410
Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice Edward M. Behrens, Scott Canna, Katharine Slade, Journal of Clinical Investigation Lymphocyte DevelopmentAdaptive Immune SystemImmunodeficienciesImmunologyImmune Regulation	2011	381
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome Eric S. Weiss, Charlotte Girard, Dirk Holzinger, Blood	2018	381
An immune-based biomarker signature is associated with mortality in COVID-19 patients Michael S. Abers, Ottavia M. Delmonte, Emily Ricotta, JCI Insight	2020	357
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 Lauren A. Henderson, Scott Canna, Kevin G. Friedman, Arthritis & Rheumatology	2022	283
Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis Rupali Das, Peng Guan, Leslee Sprague, Blood	2016	247

Page 1